Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients

Non-interventional Prospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Immunosuppressive Treatment (IST)

Investigateur principal

Régis Peffault de Latour, Antonio M. Risitano

Clonal evolution in acquired aplastic anemia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Pedro de Lima Prata

Real life analysis BV use as consolidation therapy in HL with high risk post ASCT

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Mariana Bastos Oreiro

Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis.

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Miguel-Angel Perales

Allogeneic Stem Cell TransplantationIn NK/ T-cell lymphoma

Retrospective Studies

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Norbert Schmitz

Late effects after hematopoietic stem cell transplantation in patients with HLH

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Inborn Errors Working Party (IEWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

AnnaCarin Horne

Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Jacopo Peccatori

The outcome of second and third allogeneic conditioned HSCT in patients with non-SCID primary immune deficiency (PID) following primary or secondary graft failure

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Tobias Alexander

Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Riccardo Saccardi

Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST)

Non-interventional Prospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Riccardo Saccardi